1.ICP-MS determination of ten elemental impurities in meglumine
Junmin LAI ; Zhifang LI ; Minshan ZENG ; Juan ZHANG ; Xiaohong YAN
Drug Standards of China 2024;25(5):452-457
Objective:To establish an ICP-MS method for the determination of 10 elemental impurities in meglu-mine(APIs).Methods:The samples were processed by closed high-pressure microwave digestion,and the con-tents of the Class 1 elemental impurities arsenic(As),cadmium(Cd),mercury(Hg)and lead(Pb),the Class 2 A elemental impurities cobalt(Co),nickel(Ni)and vanadium(V),and the Class 3 elemental impurities lithium(Li),antimony(Sb)and copper(Cu)were detected by ICP-MS with total quantification.Results:The linear correlation coefficients(r)of each elemental impurity were greater than 0.997.The recoveries of the spiked samples ranged from 93.6%to 116.8%with RSD values of the recoveries lower than 7.4%.RSD values of the precision were lower than 5.4%.The content of nickel in 11 batches of the samples was lower than the permissible daily exposure(PDE)of the impurities of the elements of category 2A in the elemental guideline of ICH Q3D(R2)for oral use but higher than that of PDE of the impurities of category 2A for injection.Conclusion:The method is sensitive and precise enough to accurately determine the levels of Class 1,2A and 3 elemental impurities in meglumine.Nine batches of meglumine were found to have a high risk of nickel residue.
2.Chinese expert consensus on clinical application of molecularly targeted drugs for hepatocellular carcinoma (2022 edition).
Juxian SUN ; Qiu LI ; Xueli BAI ; Jianqiang CAI ; Yajin CHEN ; Minshan CHEN ; Chaoliu DAI ; Chihua FANG ; Weidong JIA ; Xiangcheng LI ; Tianfu WEN ; Jinglin XIA ; Mingang YING ; Zhiwei ZHANG ; Xuewen ZHANG ; Zhaochong ZENG ; Shuqun CHENG
Chinese Medical Journal 2024;137(21):2630-2632

Result Analysis
Print
Save
E-mail